## Abstract Most previous studies aimed at estimating the number of human Tโcell leukemia virus typeโ1 (HTLVโ1) carriers in endemic areas have been based on seroprevalence rates in blood donors; however, this may result in underestimation because of the healthy donor effect. People who have health
Trends of incidence rate of adult T-cell leukemia/lymphoma in an HTLV-1 endemic area in Japan
โ Scribed by Kokichi Arisawa; Midori Soda; Masahito Ono; Hirokazu Uemura; Mineyoshi Hiyoshi; Akihiko Suyama
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 106 KB
- Volume
- 125
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Dear Sir, Adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature T cells which develops among individuals infected with human T-cell lymphotropic virus type-1 (HTLV-1). ATL shows characteristic geographic distribution in the world, being endemic in south-western Japan, the Caribbean region, central Africa, etc. Previous epidemiologic studies have shown that the incidence rate of ATL among carriers of HTLV-1 ranges from 0.6 to 2.0 cases/1,000 person-years, and the life-time risk of ATL from 1.0 to 6.6%. 1,2 However, there have been few reports on the secular trend of the incidence rate of ATL in geographically defined populations. In this study, the authors investigated the changes in the ATL incidence in Nagasaki Prefecture, Japan, using a population-based cancer registry. The study area of the present study was the whole of Nagasaki Prefecture, Japan, the total population of which included 726,894 men and 818,040 women in 1995. In this prefecture, a population-based cancer registry (Nagasaki Prefectural Cancer Registry, NPCR) has been operating since 1985, under the supervision of the Department of Epidemiology, Radiation Effects Research Foundation. The rate of incidence of ATL was calculated by dividing the number of cases by person-years of observation. The incident cases of ATL diagnosed from 1985 to 2004 were selected from the file of the NPCR. In the NPCR, patients satisfying the following criteria have been registered as ATL: (i) Tcell malignancy with seropositivity to HTLV-1 or (ii) clinical diagnosis of ATL. The validity of the diagnosis has been reported in a previous paper. The person-years at risk were calculated by summing the population of each year during the observation period. The age-standardized incidence rates of ATL and their 95% confidence intervals (CI) were calculated by the conventional methods, using the world population as a reference. Poisson regression analysis (SAS GENMOD procedure, version 8.2) and Mantel-Haenszel procedure were used to estimate the sex-adjusted or sex-and-age-adjusted incidence rate ratios (RR) and their 95% CI. The study protocol was reviewed and approved by the Ethical Committee of the Tokushima University Hospital. There were 1,851 registered cases of ATL (1,022 males and 829 females) between 1985 and 2004. The proportion of patients registered by the death certificates only was 8.9%. Figure shows the distribution of age at onset of
๐ SIMILAR VOLUMES
The incidence of adult T-cell leukemia/lymphoma (ATL) and its impact on that of total non-Hodgkin lymphoma (NHL) were evaluated in Nagasaki, an area in southwestern Japan where human T-cell lymphotropic virus type I (HTLV-I) is endemic. The first study area comprised 4 towns located on the K Islands
Adult T-cell leukemia/lymphoma (ATL), a rare outcome of infection with human T-lymphotropic virus (HTLV-I), is endemic in central Brooklyn, which has a large Caribbean migrant population. Previous studies have suggested that HTLV-I prevalence in central Brooklyn may be similar to that recorded in th
Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent for adult T-cell leukemia/lymphoma (ATL). [1][2][3] Only a small proportion of HTLV-1 carriers eventually develop ATL after a long latency. 4 However, the critical events in the leukemogenic process remain unclear. In general, viral l